R. Carter Pate, Director at BioScrip, Inc. (BIOS), bought 20,000 shares at $1.30 ($26K) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Open-market purchase of $26k BIOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| OPCH | SELL | 2024-09-05 | $47K | — | Filing → |
| OPCH | BUY | 2023-08-21 | $101K | — | Filing → |
| PRPL | BUY | 2023-05-15 | $50K | — | Filing → |